Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 56, Issue 6, 2007, Pages 838-846

  Ding, Shi Ying ^a   Tigno, Xenia T ^b   Hansen, Barbara C ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSLIPIDEMIA; FEMALE; GLYCEMIC CONTROL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MONKEY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIMATE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; DIABETES MELLITUS, TYPE 2; LIPOPROTEINS; MACACA MULATTA; MAGNETIC RESONANCE SPECTROSCOPY; METABOLIC SYNDROME X; PARTICLE SIZE;

EID: 34248381376     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.01.015     Document Type: Article

References (46)

1. Miranda P.J., DeFronzo R.A., Califf R.M., et al. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 149 (2005) 33-45
2. Reilly M.P., and Rader D.J. The metabolic syndrome: more than the sum of its parts?. Circulation 108 (2003) 1546-1551
3. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
4. Meigs J.B., Wilson P.W., Nathan D.M., et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52 (2003) 2160-2167
5. Haffner S., and Cassells H.B. Metabolic syndrome-a new risk factor of coronary heart disease?. Diabetes Obes Metab 5 (2003) 359-370
6. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
7. Lorenzo C., Okoloise M., Williams K., et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 (2003) 3153-3159
8. Laaksonen D.E., Lakka H.M., Niskanen L.K., et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1077
9. Ayyobi A.F., and Brunzell J.D. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Am J Cardiol 92 (2003) 27J-33J
10. Brunzell J.D., and Ayyobi A.F. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 115 Suppl 8A (2003) 24S-28S
11. Watson K.E., Horowitz B.N., and Matson G. Lipid abnormalities in insulin resistant states. Rev Cardiovasc Med 4 (2003) 228-236
12. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46 (2003) 733-749
13. Kuller L., Arnold A., Tracy R., et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arterioscler Thromb Vasc Biol 22 (2002) 1175-1180
14. Williams P.T., Superko H.R., Haskell W.L., et al. Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23 (2003) 314-321
15. Johansson J., Carlson L.A., Landou C., et al. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11 (1991) 174-182
16. Wilson H.M., Patel J.C., Russell D., et al. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin Chim Acta 220 (1993) 175-187
17. Garvey W.T., Kwon S., Zheng D., et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52 (2003) 453-462
18. MacLean P.S., Vadlamudi S., MacDonald K.G., et al. Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women. Metabolism 49 (2000) 285-292
19. Hansen B.C., and Bodkin N.L. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29 (1986) 713-719
20. Hansen B.C. Primate animal models of type 2 diabetes. In: LeRoith D., Olefsky J., and Taylor S. (Eds). Diabetes mellitus: a fundamental and clinical text. 3rd ed (2004), J.B. Lippincott, Philadelphia 1059-1074
21. Bodkin N.L., Hannah J.S., Ortmeyer H.K., et al. Central obesity in rhesus monkeys: association with hyperinsulinemia, insulin resistance and hypertriglyceridemia?. Int J Obes Relat Metab Disord 17 (1993) 53-61
22. Bodkin N.L., Metzger B.L., and Hansen B.C. Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am J Physiol 256 (1989) E676-E681
23. Hansen B.C., and Bodkin N.L. Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol 259 (1990) R612-R617
24. Hannah J.S., Verdery R.B., Bodkin N.L., et al. Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta). In J Clin Endocrinol Metab (1991) 1067-1072
25. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
26. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
27. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
28. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
29. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
30. Hanson R.L., Imperatore G., Bennett P.H., et al. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51 (2002) 3120-3127
31. Cheal K.L., Abbasi F., Lamendola C., et al. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53 (2004) 1195-1200
32. Tigno X.T., Gerzanich G., and Hansen B.C. Age-related changes in metabolic parameters of nonhuman primates. J Gerontol A Biol Sci Med Sci 59 (2004) 1081-1088
33. Otvos J.D., Jeyarajah E.J., Bennett D.W., et al. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38 (1992) 1632-1638
34. Otvos J.D. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab 48 (2002) 171-180
35. Festa A., Williams K., Hanley A.J., et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 111 (2005) 3465-3472
36. Goff D.C., D'Agostino R.B., Haffner S.M., et al. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 54 (2005) 264-270
37. Gardner C.D., Fortmann S.P., and Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276 (1996) 875-881
38. Mykkanen L., Kuusisto J., Haffner S.M., et al. LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol 19 (1999) 2742-2748
39. Caixas A., Ordonez-Llanos J., de Leiva A., et al. Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 46 (1997) 1207-1213
40. Gray R.S., Robbins D.C., Wang W., et al. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler Thromb Vasc Biol 17 (1997) 2713-2720
41. Ginsberg H.N. Treatment for patients with the metabolic syndrome. Am J Cardiol 91 (2003) 29E-39E
42. Ballantyne C.M., Olsson A.G., Cook T.J., et al. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation 104 (2001) 3046-3051
43. Kontush A., and Chapman M.J. Antiatherogenic small, dense HDL-guardian angel of the arterial wall?. Nat Clin Pract Cardiovasc Med 3 (2006) 144-153
44. Lamarche B., Moorjani S., Cantin B., et al. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 17 (1997) 1098-1105
45. Pascot A., Lemieux I., Prud'homme D., et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42 (2001) 2007-2014
46. Reaven G.M., Chen Y.D., Jeppesen J., et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92 (1993) 141-146